News tagged with androgen receptors
Studies show increasing evidence that androgen drives breast cancer
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
Counting copy numbers characterises prostate cancer
Non-invasive 'liquid biopsies' can find metastatic or recurrent prostate cancer, in a low cost assay suitable for most healthcare systems, finds research published in BioMed Central's open access journal Genome Medicine. Genomi ...
Cancer
Apr 04, 2013 |
not rated yet |
0
How some prostate tumors resist treatment—and how it might be fixed
Hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of ...
Cancer
Mar 18, 2013 |
5 / 5 (2) |
0
|
Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers ...
Cancer
Feb 20, 2013 |
5 / 5 (1) |
0
|
Researchers identify genetic root to early-onset prostate cancer
Prostate cancer is often considered an elderly man's disease, and little is known about the approximately 2% of cases that arise in men who are aged 50 years or younger. Research published in the February 11th issue of the ...
Cancer
Feb 11, 2013 |
5 / 5 (1) |
0
World-first tissue study could re-shape future of advanced prostate cancer treatment
The first-ever comprehensive study of prostate cancer tissue has revealed a completely new gene network driving the disease in patients who have stopped responding to standard hormone treatment, according ...
Cancer
Dec 21, 2012 |
not rated yet |
0
Researchers find new culprit in castration-resistant prostate cancer
Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They ...
Cancer
Dec 13, 2012 |
not rated yet |
0
|
Clinical trial hits new target in war on breast cancer
Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...
Cancer
Dec 03, 2012 |
5 / 5 (2) |
0
|
New findings on men's genes could alter interpretation of PSA test
By studying a specific part of the male DNA, it may be possible to refine the interpretation of PSA tests. This would reduce the risk of men being treated for prostate cancer unnecessarily.
Cancer
Oct 30, 2012 |
not rated yet |
0
Noninvasive assay monitored treatment response in patients with metastatic prostate cancer
Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients' blood, according to data published ...
Cancer
Oct 23, 2012 |
not rated yet |
0
|
Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. ...
Neuroscience
Oct 15, 2012 |
5 / 5 (2) |
0
Like prostate cancer, bladder cancer patients may benefit from anti-androgen therapy
Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A University of Colorado Cancer Center study published today in the Proceedings of the National Ac ...
Cancer
Sep 24, 2012 |
5 / 5 (1) |
0
|
Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Cancer
Sep 17, 2012 |
not rated yet |
0
Reducing the side effects of treatment for prostate cancer
New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an ant ...
Cancer
Aug 27, 2012 |
4.5 / 5 (2) |
0
Enzalutamide adds five months survival in late-stage prostate cancer
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer ...
Cancer
Aug 16, 2012 |
5 / 5 (1) |
0